Skip to main content
Cube Labs S.p.A. logo

Cube Labs S.p.A. — Investor Relations & Filings

Ticker · CUBE ISIN · IT0005532483 LEI · 815600566D45248BEB28 XMIL Professional, scientific and technical activities
Open in API
Filings indexed 131 across all filing types
Latest filing 2023-07-24 Share Issue/Capital Cha…
Country IT Italy
Listing XMIL CUBE

About Cube Labs S.p.A.

https://cube-labs.com/

Cube Labs S.p.A. is a venture builder specializing in the healthcare technology and life sciences sectors. The company's model focuses on identifying promising academic research and development and transforming it into commercial enterprises. It creates and nurtures startups to bridge the gap between scientific discovery and market-ready healthcare solutions. The firm's investment and development activities cover key areas including pharmaceuticals, biotechnology, medical technology (MedTech), nutraceuticals, and the application of artificial intelligence in R&D. A core part of its mission is to make research, technologies, and tools more accessible, fostering open innovation and collaboration to accelerate the development of new healthcare technologies.

Recent filings

Filing Released Lang Actions
AVVIO COLLOCAMENTO DI AZIONI RISERVATO A INVESTITORI QUALIFICATI
Share Issue/Capital Change Classification · 99% confidence The document is an official communication (Informazione Regolamentata) from Cube Labs, dated July 24, 2023, announcing the 'AVVIO COLLOCAMENTO DI AZIONI RISERVATO A INVESTITORI QUALIFICATI' (Start of placement of shares reserved for qualified investors). The core subject is the offering and placement of new shares (Nuove Azioni) to raise capital, with a maximum value of Euro 500,000.00. This activity directly relates to fundraising, financing activities, and changes in capital structure. Therefore, it fits the definition of 'Capital/Financing Update' (CAP). It is not a full annual report (10-K), an earnings release (ER), or a dividend notice (DIV).
2023-07-24 Italian
CUBE LABS PARTECIPA ALLA QUARTA EDIZIONE DELLA “MID & SMALL VIRTUAL”
Regulatory Filings Classification · 100% confidence The document is titled 'Comunicato Stampa' (Press Release) and announces the company's participation in a virtual event ('Mid & Small Virtual') where management will present financial results and growth strategies to investors. The key subject is the announcement of an event where presentations will occur, rather than the presentation itself or a formal regulatory filing like a 10-K or IR. The text explicitly states 'Vedi allegato' (See attachment) and provides contact information for media and investor relations, typical of a brief announcement. Since it is an announcement about engaging with investors and presenting results, it aligns best with an Investor Presentation (IP) or a general Regulatory Filing (RNS). Given that the core purpose is to inform the market about management's upcoming engagement with investors to discuss strategy and financials, 'Investor Presentation' (IP) is a strong candidate if the actual presentation material was attached. However, the document itself is just the announcement of attendance at a conference where they *will* present. Because it is a short press release announcing participation in an investor event, and the actual detailed financial/strategy presentation is likely a separate document, this functions as a general market communication. Since it is not a formal regulatory filing (like 10-K, IR, ER) but a specific announcement about investor engagement, and it doesn't fit perfectly into the other specific categories, the most appropriate classification is the general Regulatory Filings (RNS) as a fallback for non-standard announcements, or potentially IP if we assume the announcement implies the presentation material is forthcoming/attached. Given the structure and content (announcing participation in a conference where they will present), it is most closely related to investor communication, but since it's just the announcement, RNS is the safest general classification, or RPA if it were announcing the *release* of a report. Since it announces participation in an event where they will present, and the document itself is short, I will lean towards RNS as a general regulatory announcement about corporate activity, although IP is contextually close.
2023-06-27 Italian
CUBE LABS: CARTILAGO BREVETTA IN USA TECNOLOGIE INNOVATIVE CONTRO L’OSTEOARTRITE
Regulatory Filings Classification · 95% confidence The document is titled 'Informazione Regolamentata' (Regulated Information) and is explicitly labeled as a 'Comunicato Stampa' (Press Release). The content announces a specific business event: Cartilago (a subsidiary of Cube Labs) receiving a patent grant in the USA (USPTO). This type of announcement, detailing a significant operational or legal development (patent grant), is typically disseminated via a press release to inform the market broadly. Since it is a direct announcement of news rather than a comprehensive periodic report (like 10-K or IR) or a transcript, it fits best under the general category for regulatory announcements that aren't covered by more specific codes like DIV, DIRS, or MANG. Given the options, 'Regulatory Filings' (RNS) serves as the appropriate fallback for general, non-periodic, material news releases that don't fit other specific categories, although 'LTR' (Legal Proceedings Report) might seem related due to the patent, the core event is the *grant* announcement, making RNS more suitable for a general press release format.
2023-06-16 Italian
CUBE LABS S.P.A.: RESO DISPONIBILE IL VERBALE DELL’ASSEMBLEA DEGLI AZIONISTI E IL RENDICONTO SINTENTICO DELLE VOTAZIONI
Declaration of Voting Results & Voting Rights Announcements Classification · 99% confidence The document is a regulatory announcement (Informazione Regolamentata) from CUBE LABS dated June 7, 2023. The subject ('Oggetto') explicitly states: 'AZIONISTI E IL RENDICONTO SINTENTICO DELLE VOTAZIONI' (Shareholders and the Synthetic Report of Voting) and 'RESO DISPONIBILE IL VERBALE DELL'ASSEMBLEA DEGLI AZIONISTI' (The Minutes of the Shareholders' Meeting are made available). This indicates the document is announcing the availability of the minutes and voting results from a past Shareholders' Meeting (held May 15, 2023). This directly corresponds to the definition of 'Declaration of Voting Results & Voting Rights Announcements' (DVA), which covers official results from shareholder votes. Although it mentions the minutes ('verbale'), the core purpose is announcing the voting results summary ('rendiconto sintetico delle votazioni'). Given the short length (4269 chars) and the phrasing 'Vedi allegato' (See attachment) and 'reso disponibile' (made available), it fits the RPA/RNS category if it were just announcing a report, but DVA is more specific for voting results documentation.
2023-06-07 Italian
BIODIAPERS SRL, START UP CONTROLLATA DA CUBE LABS, SIGLA ACCORDO CON SICAM SRL PER LO SVILUPPO DI UN PROTOTIPO INDUSTRIALE
Regulatory Filings Classification · 95% confidence The document is titled 'Comunicato Stampa' (Press Release) and details a specific business agreement between Biodiapers SRL (a subsidiary of Cube Labs) and Sicam SRL regarding the development of an industrial prototype for absorbent products. The metadata indicates it was received on May 31, 2023, and is classified as 'REGEM' (Regulated Information) on Euronext Growth Milan. This type of announcement, detailing a significant operational agreement, partnership, or development that is not a full financial report (like 10-K or IR) or a simple dividend/share change, typically falls under general regulatory announcements or specific business updates. Since there is no specific code for 'Business Development/Partnership Announcement' and it is a formal, regulated communication, it best fits the general 'Regulatory Filings' (RNS) category, which serves as a fallback for significant, non-standard announcements, or potentially 'LTR' if it were legal, or 'TAR' if it were M&A, neither of which apply here. Given the context of regulated news dissemination for material business events, RNS is the most appropriate general classification.
2023-05-31 Italian
L’ASSEMBLEA ORDINARIA DEGLI AZIONISTI DI CUBE LABS S.P.A. HA APPROVATO IL BILANCIO DI ESERCIZIO AL 31 DICEMBRE 2022 E LA DESTINAZIONE DEL RISULTATO
Audit Report / Information Classification · 95% confidence The document is an official communication (Informazione Regolamentata) from Cube Labs S.p.A. dated May 15, 2023. The subject explicitly states that the Ordinary Shareholders' Meeting approved the Financial Statements (Bilancio di Esercizio) for the year ended December 31, 2022, and the allocation of the result. The text then provides key financial highlights (Revenue, EBITDA, Net Result, Net Financial Debt) from this approved annual report. Although it discusses the annual financial results, the document itself is a press release/communication *announcing* the approval of the annual report by the AGM, rather than the full 10-K report itself. Since the AGM approved the annual financial statements, and the document summarizes the key outcomes of that meeting regarding the financials, it strongly relates to the Annual General Meeting (AGM-R) or the underlying financial report approval. Given the focus on the AGM approving the annual accounts and the inclusion of key financial metrics, AGM-R is the most appropriate classification, as it is the official record of the AGM's decisions regarding the annual accounts. It is not the full 10-K, nor is it just a standard Earnings Release (ER) which usually precedes the AGM approval. FY 2022
2023-05-15 Italian

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.